Spots Global Cancer Trial Database for Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Official Title: A Single-arm, Open-lable, Multicenter, Phase II Clinical Study of HX008 in Subjects With BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Study ID: NCT04738630
Conditions
Interventions
Study Description
Brief Summary: This is a single-arm, multicenter study to evaluate the efficacy and safety of HX008 injection in patients with BCG-unresponsive non-muscle invasive bladder cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Union Hospital Affiliated to Tongji Medical College, Huazhong University of science and technology, Wuhan, Hubei, China
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology, Wuhan, Hubei, China
Hunan Cancer Hospital, Changsha, Hunan, China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
The First Affiliated Hospital of Chongqing Medical University, Chongqing, Sichuan, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
